PMID: 22216522Dec 1, 1976Paper

The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics

British Journal of Clinical Pharmacology
H Formgren


The effect of metoprolol, a new beta1-adrenoceptor blocking agent, was compared to practolol in the treatment of hypertension in seventeen asthmatics during concurrent optimum bronchodilator therapy with a selective beta2-adrenoceptor-stimulant. The two beta-adrenoceptor antagonists were given at two dose levels, practolol (200 mg and 400 mg) daily, and metoprolol (100 mg and 200 mg) daily, in a twice-daily dosage schedule, at 12 h intervals, for 17 days. The comparison was made double-blind and a crossover design was used. The drugs were given in randomized order. The study started with a run-in placebo period and there was a washout period on placebo between the treatment periods. Spirometry, blood pressures and heart rates were recorded in a standardized manner. At the lower dose levels no influence on FEV1 was noted, and no difference was found between the two active drugs. At the higher dose level FEV1 was reduced by both beta-adrenoceptor-blocking drugs. Four out of twelve patients given the higher dose experienced exacerbation of their asthma. The heart rate fell with both drugs and at both dose levels. During the placebo period a marked increase of heart rate was noted. The blood pressure fell at both dose levels compar...Continue Reading


Feb 1, 1973·Life Sciences. Pt. 1: Physiology and Pharmacology·B ABLADL Ek
Nov 9, 1974·British Medical Journal·R H FelixM G Dahl
Dec 14, 1974·British Medical Journal·E B Raftery
Sep 15, 1966·The New England Journal of Medicine·G Zaid, G N Beall


Jan 1, 1991·Cardiovascular Drugs and Therapy·A E Tattersfield
Jan 1, 1984·European Journal of Clinical Pharmacology·J S Gill, D G Beevers
Jan 1, 1985·European Journal of Clinical Pharmacology·P ZanonF Pamparana
Jan 1, 1986·European Journal of Clinical Pharmacology·J LicheyT Friedrich
Jan 1, 1981·European Journal of Clinical Pharmacology·M E EllisS H Ellis
Jun 1, 1993·Cardiovascular Drugs and Therapy·L Arcavi, N L Benowitz
Apr 15, 1986·Klinische Wochenschrift·P Dorow, W Schiess
Jan 1, 1983·Pharmacology & Therapeutics·A J Scriven, P J Lewis
Jan 1, 1990·Pharmacology & Therapeutics·T H Pringle, J G Riddell
Sep 27, 1979·The New England Journal of Medicine·J Koch-Weser
Dec 16, 1982·The New England Journal of Medicine·M S LennardH F Woods
Jun 1, 1978·British Journal of Clinical Pharmacology·C R Kumana, R Ruffin
Jan 1, 1985·Current Medical Research and Opinion·P F Crowe, R J Ferguson
Mar 1, 1984·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G SuginoD T O'Connor
Nov 1, 1980·Chest·J W Jenne
Jul 1, 1983·The American Journal of Cardiology·C M PrattM A Quinones
Feb 1, 1982·British Journal of Clinical Pharmacology·S Freestone, L E Ramsay
Aug 1, 1982·British Journal of Clinical Pharmacology·M S LennardJ Trevethick
Mar 1, 1986·British Journal of Clinical Pharmacology·T H PringleR G Shanks
Jan 1, 1984·British Journal of Clinical Pharmacology·J H SilasH F Woods
Sep 15, 2012·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Timothy SelfJudith E Soberman
Aug 1, 1982·American Heart Journal·P von Wichert
Jun 20, 2002·Archives of Environmental Health·Orjan Hallberg, Olle Johansson
Jun 19, 2001·The Cochrane Database of Systematic Reviews·S SalpeterE Salpeter
Feb 1, 1978·British Heart Journal·P B DecalmerG M Sterling
Jul 1, 1982·Pediatric Annals·L Reisman, R V Selden
Jun 16, 2005·QJM : Monthly Journal of the Association of Physicians·M EgredE Rodrigues
Mar 29, 2014·The Cochrane Database of Systematic Reviews·Thordis ThomsenAnn Merete Møller
Feb 1, 1980·Thorax·N BerendG E Marlin
Jun 15, 1985·British Medical Journal·R M Jones
Apr 2, 2015·The European Respiratory Journal·Bartolome R CelliATS/ERS Task Force for COPD Research
May 1, 1979·Postgraduate Medicine·J R Caldwell
Jan 23, 2004·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Timothy SelfCarol C Chafin

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.